Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Neutron Science (4)
- Biological Systems (1)
- Biology and Environment (20)
- Clean Energy (25)
- Computer Science (1)
- Fusion and Fission (9)
- Fusion Energy (1)
- Materials (13)
- Materials for Computing (1)
- National Security (11)
- Nuclear Science and Technology (2)
- Quantum information Science (1)
- Supercomputing (12)
News Topics
- (-) Bioenergy (2)
- (-) Biomedical (1)
- (-) Cybersecurity (2)
- (-) Nuclear Energy (1)
- (-) Sustainable Energy (2)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (1)
- Biology (2)
- Clean Water (1)
- Computer Science (4)
- Decarbonization (1)
- Energy Storage (4)
- Environment (4)
- Frontier (1)
- Machine Learning (1)
- Materials (3)
- Materials Science (3)
- National Security (1)
- Neutron Science (18)
- Physics (2)
- Quantum Science (1)
- Security (1)
- Space Exploration (1)
- Summit (1)
Media Contacts
Oak Ridge National Laboratory’s Innovation Crossroads program welcomes six new science and technology innovators from across the United States to the sixth cohort.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
Illustration of the optimized zeolite catalyst, or NbAlS-1, which enables a highly efficient chemical reaction to create butene, a renewable source of energy, without expending high amounts of energy for the conversion. Credit: Jill Hemman, Oak Ridge National Laboratory/U.S. Dept. of Energy
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
Researchers at the Department of Energy’s Oak Ridge National Laboratory, Pacific Northwest National Laboratory and Washington State University teamed up to investigate the complex dynamics of low-water liquids that challenge nuclear waste processing at federal cleanup sites.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.